Baronsmead Venture Trust Plc (LON:BVT - Get Free Report) insider Michael Probin purchased 22,673 shares of the business's stock in a transaction dated Thursday, February 20th. The stock was bought at an average price of GBX 53 ($0.67) per share, for a total transaction of £12,016.69 ($15,182.17).
Baronsmead Venture Trust Stock Performance
BVT stock traded down GBX 0.80 ($0.01) on Friday, hitting GBX 48.20 ($0.61). 13,500 shares of the company's stock were exchanged, compared to its average volume of 185,116. Baronsmead Venture Trust Plc has a 12-month low of GBX 46 ($0.58) and a 12-month high of GBX 56 ($0.71). The firm has a 50 day moving average price of GBX 51.37 and a two-hundred day moving average price of GBX 52.41. The stock has a market cap of £187.10 million, a P/E ratio of 14.09 and a beta of 0.19.
Baronsmead Venture Trust (LON:BVT - Get Free Report) last announced its earnings results on Tuesday, December 24th. The company reported GBX 0.53 ($0.01) earnings per share for the quarter. Baronsmead Venture Trust had a return on equity of 6.22% and a net margin of 75.56%.
Baronsmead Venture Trust Increases Dividend
The firm also recently announced a dividend, which will be paid on Monday, March 17th. Investors of record on Thursday, February 13th will be paid a dividend of GBX 2 ($0.03) per share. This represents a yield of 3.85%. This is an increase from Baronsmead Venture Trust's previous dividend of $1.75. The ex-dividend date of this dividend is Thursday, February 13th. Baronsmead Venture Trust's payout ratio is 116.95%.
Baronsmead Venture Trust Company Profile
(
Get Free Report)
Baronsmead Venture Trust Plc is a venture capital trust managed by ISIS Equity Partners LLP. It invests in a portfolio of unquoted companies in the United Kingdom, which raise expansion capital or are the subject of a management buy-out or buy-in. The trust primarily invests in the media, business services, consumer, information technology support services, and healthcare sectors.
See Also
Before you consider Baronsmead Venture Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Baronsmead Venture Trust wasn't on the list.
While Baronsmead Venture Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
